金斯瑞生物科技(01548)今日盘中大涨5.34%,报收10.93港元,市值约66亿港元。
消息面上,CRO概念股早盘集体回暖,多只个股均现涨幅,引发市场对整个CRO行业前景的关注。分析师表示,随着海外投融资逐渐恢复、新兴细分领域如ADC、多肽及小核酸药物快速发展,预计CRO行业将迎来长期增长机遇。作为国内CRO行业的龙头企业,金斯瑞生物科技有望充分受益。
此外,南向资金近期也频繁加仓金斯瑞生物科技。截至11月26日,南向资金连续5日增持该股,当日净买入108.6万股,显示出资金对公司长期发展前景的看好。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.